$2.35
-0.08-3.29%
Pre-Market: Sep 23, 8:25 AM EDT
15 minutes delayed
Aytu BioPharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aytu BioPharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $-0.52 | $-0.64 | 18.8 % |
Dec 2023 | 2024-02-14 | $-0.04 | $-0.25 | 84.0 % |
Jun 2023 | 2023-09-27 | $-0.59 | $-0.95 | 37.9 % |
Mar 2023 | 2023-05-11 | $-1.93 | $-0.63 | -206.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-15 | $17.99M | $17.35M | 3.71 % |
Dec 2023 | 2024-02-14 | $22.93M | $21.75M | 5.47 % |
Sep 2023 | 2023-11-14 | $22.10M | $27.73M | -20.3 % |
Jun 2023 | 2023-09-27 | $30.73M | $27.69M | 11.0 % |
Aytu BioPharma (AYTU) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on May 15, 2024 for Q3.
The Actual EPS was $-0.52, which beat the estimate of $-0.64.
The Actual Revenue was $18M, which beat the estimate of $17.4M.
Browse earnings estimates, EPS, and revenue on all stocks.